Welcome to our dedicated page for UNILEVER PLC SEC filings (Ticker: UL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UNILEVER PLC's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UNILEVER PLC's regulatory disclosures and financial reporting.
Unilever PLC reported multiple share transactions by senior leaders under its incentive plans. On 12 February 2026, several executives received Unilever PLC ordinary 3 1/2 pence shares through vesting of Performance Share Plan (PSP) and Target Share Award (TSA) grants, mostly outside a trading venue.
Chief Executive Officer Fernando Fernandez saw 17,327.697378 PSP shares vest at £53.55 and sold 17,327 shares at a weighted average £52.50 on the London Stock Exchange. President 1 Unilever Markets Reginaldo Ecclissato had 17,003.816556 PSP shares vest at £53.55 and sold 17,003 shares at a weighted average €59.41 on the Amsterdam exchange, while other Unilever Leadership Executive members recorded only vestings.
Unilever PLC reports a change in external responsibilities for one of its board members. Susan Kilsby, currently a non-executive director, Vice Chair and Senior Independent Director of Unilever, will serve as Executive Chair of Fortune Brands Innovations from 12 February 2026. She will also assume the duties of Chief Executive Officer there during a transition period from 1 April 2026 until 13 May 2026, after which she will return to her role as Chair of Fortune Brands Innovations. The notice does not announce any change to her roles at Unilever.
Unilever PLC has published a new Supplement, dated 12 February 2026, to the existing U.S.$25,000,000,000 Debt Issuance Programme of Unilever Finance Netherlands B.V., Unilever Capital Corporation and Unilever PLC as issuers, with Unilever PLC and Unilever United States, Inc. as guarantors. The Supplement has been approved by the UK Financial Conduct Authority and must be read together with the Information Memorandum dated 16 May 2025 and prior supplements from 31 July 2025 and 24 October 2025. Links are provided for investors to access the Supplement and related documents, which will also be available via the FCA’s National Storage Mechanism.
Unilever PLC delivered modest growth in 2025 while reshaping its portfolio through the demerger of Ice Cream and targeted deals. Underlying sales grew 3.5% with 1.5% volume and 2.0% price, while reported turnover fell 3.8% to €50.5 billion, mainly due to currency and disposals.
Profitability improved, with underlying operating margin up 60bps to 20.0% and gross margin rising to 46.9% as productivity savings and cost discipline offset inflation and FX. Underlying EPS increased to €3.08 and diluted EPS to €2.59. Free cash flow was strong at €5.9 billion with 100% cash conversion.
Unilever completed the Ice Cream demerger, retaining a 19.9% stake in The Magnum Ice Cream Company and recording a €3.4 billion gain from discontinued operations. It returned €6.0 billion to shareholders in 2025 via dividends and buybacks and approved a new share buyback of up to €1.5 billion, expected to start in the second quarter of 2026. Management expects 2026 underlying sales growth within a 4%–6% range, with at least 2% volume growth and a modest margin improvement versus 2025.
Unilever PLC has issued and admitted to trading 4,200,000 new ordinary shares of 3 1/2p each on the London Stock Exchange Main Market to satisfy vesting of awards under its employee share schemes.
Following this issuance, Unilever has 2,185,205,247 ordinary shares admitted. A further 1,577,778 ordinary shares remain available under the existing block admission dated 14 March 2024. The new shares rank equally with all existing ordinary shares.
Unilever PLC reports an update on its voting rights and share capital. As at 30 January 2026, the company had issued 2,181,005,247 ordinary shares of 3 1/2p each. None of these were held as treasury shares, but 314,912 shares were held by Unilever group companies, and the voting rights on those shares cannot be used.
This means there were 2,180,690,335 Unilever PLC shares with voting rights on that date. Shareholders can use this voting-share figure as the denominator when calculating whether they must disclose a new or changed holding under the UK Financial Conduct Authority’s transparency rules.
Unilever PLC filed an amended report to correct a prior update on its voting rights and share capital. The earlier announcement misstated the number of ordinary shares held by Unilever group companies, which in turn affected the quoted figure for shares with voting rights.
As at 31 December 2025, Unilever PLC had 2,181,005,247 ordinary shares of 3 1/2p each in issue, with no shares held in treasury. Of these, 314,912 ordinary shares (including those represented by ADSs) were held by or on behalf of Unilever group companies and their voting rights are not exercisable. This leaves 2,180,690,335 shares with voting rights, which shareholders may use as the denominator when assessing whether they must notify their holdings under UK disclosure rules.
Unilever PLC reports updated voting rights and share capital information as at 31 December 2025. The company’s issued share capital consisted of 2,181,005,247 ordinary shares of 3 1/2p each. None of these ordinary shares were held as treasury shares. A total of 319,412 ordinary shares, including shares represented by Unilever PLC ADSs, were held by or on behalf of companies in the Unilever group and the voting rights on these shares are not exercisable.
As a result, there were 2,180,685,835 shares with voting rights on that date. Shareholders may use this figure as the denominator when calculating whether they need to notify their interest, or any change in their interest, in Unilever PLC under the UK Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.
Unilever PLC reported a series of insider share transactions in which senior executives acquired additional ordinary shares through automatic dividend reinvestment arrangements. These transactions involved Unilever PLC ordinary 3 1/2 pence shares, with purchases executed on the London Stock Exchange and the Amsterdam Stock Exchange on 10 December 2025.
Participants included the Chief Financial Officer, Business Group Presidents, the Chief People Officer, the Chief Research & Development Officer, the Chief Supply Chain and Operations Officer, the Chief Legal Officer and Group Secretary, and the CEO & Managing Director of Hindustan Unilever Limited. Prices paid were £48.2368 per share for trades in GBP and €55.1553 per share for trades in EUR, reflecting reinvestment of cash dividends on beneficially owned shares during an open period.
Unilever PLC has cancelled 51,625,153 ordinary shares that were held in treasury, under section 729 of the UK Companies Act 2006. This cancellation took effect on 10 December 2025.
Following the cancellation, Unilever has 2,181,005,247 ordinary shares in issue and no shares held in treasury. Of these, 314,912 ordinary shares (including those represented by Unilever PLC ADSs) are held by Unilever group companies and their voting rights are not exercisable. As a result, there are 2,180,690,335 shares with voting rights, which shareholders may use as the denominator for UK disclosure and transparency calculations.